• Product name

    Anti-Gastric Mucin/MUC-6 antibody [CLH5] - BSA and Azide free
    See all Gastric Mucin/MUC-6 primary antibodies
  • Description

    Mouse monoclonal [CLH5] to Gastric Mucin/MUC-6 - BSA and Azide free
  • Host species

  • Tested applications

    Suitable for: IHC-P, Flow Cyt, ICC/IFmore details
  • Species reactivity

    Reacts with: Human
  • Immunogen

    Synthetic peptide corresponding to Human Gastric Mucin/MUC-6. (From Gastric Mucin tandem repeat sequence).
    Database link: Q6W4X9

  • Positive control

    • Human gastric carcinoma and stomach tissues.
  • General notes

    Previously labelled as Gastric Mucin.



Our Abpromise guarantee covers the use of ab212646 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IHC-P Use a concentration of 2 - 4 µg/ml. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.

(Primary incubation for 30 minutes at RT).

Flow Cyt Use 0.5-1µg for 106 cells.

(in 0.1 ml).

ICC/IF Use a concentration of 1 - 2 µg/ml.


  • Function

    May provide a mechanism for modulation of the composition of the protective mucus layer related to acid secretion or the presence of bacteria and noxious agents in the lumen. Play an important role in the cytoprotection of epithelial surfaces and are used as tumor markers in a variety of cancers. May play a role in epithelial organogenesis.
  • Tissue specificity

    Expressed in the regenerative zone of gastric antrum, gastric body mucosa and gastric incisura mucosa. Expressed in the deeper mucous glands of gastric antrum. Overexpressed in Helicobacter pylori infected gastric epithelium. Highly expressed in duodenal Brunner's glands, gall bladder, seminal vesicle, pancreatic centroacinar cells and ducts, and periductal glands of the common bile duct.
  • Sequence similarities

    Contains 1 CTCK (C-terminal cystine knot-like) domain.
    Contains 1 TIL (trypsin inhibitory-like) domain.
    Contains 3 VWFD domains.
  • Developmental stage

    Early expressed in fetal development and was observed in Brunner's glands and pancreatic ducts at 18-19 weeks and in gastric glands at 20 weeks of gestation. Expressed transiently in the nephrogenic zone of the kidney in the early mid-trimester of development. Detected in the epithelium of ureteric buds at 13 weeks and at lower levels from 17 to 23 weeks of gestation.
  • Post-translational

  • Cellular localization

  • Information by UniProt
  • Database links

  • Alternative names

    • Gastric mucin 6 antibody
    • Gastric Mucin antibody
    • Gastric mucin-6 antibody
    • MUC 6 antibody
    • MUC-6 antibody
    • Muc6 antibody
    • MUC6 Fragment antibody
    • MUC6 mucin antibody
    • MUC6 mucin Fragment antibody
    • MUC6_HUMAN antibody
    • Mucin 6 antibody
    • Mucin 6 gastric antibody
    • Mucin 6 oligomeric mucus/gel forming antibody
    • Mucin glycoprotein Fragment antibody
    • Mucin-6 antibody
    • Secretory mucin MUC6 Fragment antibody
    see all


  • Immunohistochemical analysis of formalin-fixed, paraffin-embedded Human gastric carcinoma tissue labeling Gastric Mucin/MUC-6 with ab212646 at 4 μg/ml dilution.


ab212646 has not yet been referenced specifically in any publications.

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab212646.
Please use the links above to contact us or submit feedback about this product.

For licensing inquiries, please contact partnerships@abcam.com

Sign up